Director, Clinical Pharmacology and Pharmacometrics
- Employer
- Dyne Therapeutics
- Location
- Waltham, MA
- Start date
- Nov 21, 2024
View more categoriesView less categories
- Discipline
- Clinical, Clinical Research, Science/R&D, Pharmacokinetics
- Required Education
- Doctorate/PHD/MD
- Position Type
- Full time
- Hotbed
- Genetown
Job Details
Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases. With its proprietary FORCE™ platform, Dyne is developing modern oligonucleotide therapeutics that are designed to overcome limitations in delivery to muscle tissue. Dyne has a broad pipeline for serious muscle diseases, including clinical programs for myotonic dystrophy type 1 (DM1) and Duchenne muscular dystrophy (DMD), and a preclinical program for facioscapulohumeral muscular dystrophy (FSHD).
Role Summary:
The Director, Clinical Pharmacology and Pharmacometrics is responsible for providing strategies, plans and deliverables on pharmacology and related pharmacometrics & quantitative analytics, for the advancement of select programs across all stages of drug development at Dyne Therapeutics. Primary responsibilities include the strategic planning and execution of translational & clinical pharmacology activities, as a core member of program teams, in seamless coordination and collaboration with other internal functions and subject matter experts (SMEs).
The person in this role has a strong knowledge of best practices in Clinical Pharmacology and Pharmacometrics, hands-on experience in designing and executing clinical pharmacology studies and PK/PD modeling plans, and the ability to make data-driven decisions and contributions towards clinical development strategies, clinical trial design strategies, and dosing decisions, based on preclinical, clinical and natural history information. The person in this role works seamlessly with colleagues in the Translational Biomarkers & Pharmacology department and, as a core member of high-paced program teams, with SMEs in platform discovery, preclinical research, clinical development, clinical operations, regulatory, CMC and program management, enabling IND submissions, initiation of clinical development programs, late-stage development, and interactions with Health Authorities.
This role is based in Waltham, MA without the possibility of being a remote role.
Primary Responsibilities Include:
- Provide strategies and plans for integrative clinical pharmacology, quantitative data analytics including PK/PD modeling, and translational biomarkers, in alignment with Regulatory requirements as well as corporate and R&D goals, thereby enabling the advancement of Dyne programs across all stages of drug development
- Represent the Translational Biomarkers & Pharmacology department as SME, providing expertise and guidance on pharmacology and quantitative PK/PD to R&D program teams and in close collaboration with Medical, Biometrics, Pharmacovigilance, Preclinical Tox and ADME/DMPK SMEs.
- Identify and manage consultants and vendors to support clinical pharmacology and related activities
- Author high quality regulatory documents
- Accountable for adherence to agreed timelines and budgets to ensure execution of deliverables from Clinical Pharmacology studies and drug development programs
- Collaborate cross functionally with all relevant areas to support corporate objectives
Education and Skills Requirements:
- PhD, PharmD, or equivalent training in Pharmacology, Pharmaceutical Sciences, Engineering, with 10+years of bio/pharmaceutical industry drug development experience in Pharmacology- or Biomarker-related functions
- Strong understanding of Clinical Pharmacology principles, PK/PD modeling and simulation, the drug development process and regulatory guidances, particularly around oligonucleotides and biologics (including antibody-drug conjugates), molecular delivery systems, and rare diseases
- Experience with the preparation of Clinical Pharmacology portions of regulatory documents such as pre-IND, IND, IB, briefing documents, clinical study reports, CTA, and BLA
- Ability to devise innovative dosing strategies in a data-driven manner for novel classes of molecular drug & delivery modalities
- Strong interpersonal and relationship building skills with demonstrated experience to lead and influence within a matrixed environment
- Ability to work and communicate in an open and clear manner, listening effectively and inviting responses and discussions with internal and external partners
- Independent and highly motivated, with the ability to multi-task, drive strategy and execution, in a fast-paced and fluid collaborative environment
#LI-Onsite
The statements contained herein reflect general details as necessary to describe the principles functions for this job, the level of knowledge and skill typically required, and the scope of responsibility, but should not be considered an all-inclusive listing of work requirements. Individuals may perform other duties as assigned, including work in other functional areas to cover absences or relief, to equalize peak work periods or otherwise balance workload.
This description is not intended to be constructed as an exhaustive list of duties, responsibilities, or requirements for the position. This position may change or assume additional duties at any time. The employee may be requested to perform different or additional duties as assigned. All Employees are expected to adhere to all company policies and act as a role model for company values.
Dyne Therapeutics is an equal opportunity employer and will not discriminate against any employee or applicant on the basis of age, color, disability, gender, national origin, race, religion, sexual orientation, veteran status, or any classification protected by federal, state, or local law.
Company
Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases. With its proprietary FORCE™ platform, Dyne is developing modern oligonucleotide therapeutics that are designed to overcome limitations in delivery to muscle tissue. Dyne has a broad pipeline for serious muscle diseases, including clinical programs for myotonic dystrophy type 1 (DM1) and Duchenne muscular dystrophy (DMD) and a preclinical program for facioscapulohumeral muscular dystrophy (FSHD). For more information, please visit https://www.dyne-tx.com, and follow us on X and Facebook.
CONNECT
Stock Symbol: DYN
Stock Exchange: Nasdaq
- Website
- https://www.dyne-tx.com/
- Location
-
1560 Trapelo Road
Waltham
MA
02451
United States
Get job alerts
Create a job alert and receive personalized job recommendations straight to your inbox.
Create alert